Harmonizing Immunotherapy: Tuning T Cells to Give Cancer the Blues

“No child should die at the dawn of life.” 

Danny Thomas’ inspiring credo continues to serve as motivation for researchers around the world to pursue discovery and translate it into life-saving therapies. The scientific pursuits centered on the riddles of T cell immunity embody Danny’s philosophy and have given the world a new way to combat cancer; immunotherapy.

St Jude Children’s Research Hospital and Technical University of Munich are proud to host the ‘ImmunoMemphis’ symposium where the immunological community will come together in Memphis, Tennessee to discuss fundamental mechanisms of T cell differentiation, and how these insights can be translated into durable immunotherapies for cancer and chronic viral infections.

Topics will include conceptual and technical advances that are reshaping our understanding of T cell immunological memory, current barriers in establishing T cells with tissue/tumor-homing properties, resistance to local-immunosuppression, and the capacity for establishing disease control with long-term immunological protection.

Our worldclass symposium will foster dialogue around the key unresolved questions in T cell biology with the goal of tuning T cells to give cancer the blues.